Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients (MMCR)

This study has been terminated.
(Poor recruitment.)
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Ramesh Prasad, St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier:
NCT01213394
First received: September 28, 2010
Last updated: April 18, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)